Pacific Perspectives
Stock futures are flat after a 4-day losing streak for S&P 500: Live updates
Stock futures were little changed in overnight trading Wednesday following a four-day losing streak for the S&P 500 as tech names dragged the broader market lower. Futures on the Dow Jones Industrial Average were flat. S&P 500 futures and Nasdaq…
Crypto stocks tumble as investors go into risk-off mode
Crypto stocks suffered Tuesday as investors fled tech stocks and riskier corners of the market. Among crypto exchanges, Coinbase and eToro fell more than 5% and 6%, respectively, while Robinhood and Bullish both dropped more than 6%. Crypto financial services firm Galaxy Digital tumbled 10%.…
Santos shock delay a reminder of who it is really dealing with
If the United Arab Emirates wants more time to buy Santos, it should have to pay for it. Santos’ board gave it exclusive due diligence and a nod at $US5.76 a share (then worth $8.89,…
ASX buyback bonanza intensifies as boards woo investors
Australia’s largest companies have already announced $5 billion worth of new buybacks this earnings season as an increasing number of boards opt to use the excess cash to repurchase stock rather than return the money…
CSL share plunge delivers killer blow to active fund managers
As if this year couldn’t get any tougher for the fund managers who are paid to beat the Australian sharemarket. They were already sick and tired of explaining to clients why they didn’t own enough Commonwealth…
Stock futures are little changed as investors await retail earnings, Fed minutes: Live updates
Stock futures are near flat Tuesday night as investors braced for earnings reports from major retailers and the Federal Reserve’s latest meeting minutes. Dow Jones Industrial Average futures added 13 points, or 0.03%. S&P 500 futures and Nasdaq 100…
Eli Lilly’s 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump’s pricing pressures
Eli Lilly’s move to raise the U.K. list price of its blockbuster diabetes drug Mounjaro marks the start of prices hikes across Europe, analysts say, as pharmaceutical firms respond to U.S. President Donald Trump’s drug pricing demands.…
Ryan Stokes flags acquisitions for SGH, attacks Abu Dhabi bid for Santos
Ryan Stokes says the proposed $36 billion takeover offer for Santos by the Abu Dhabi National Oil Company and US private equity giant The Carlyle Group could be highly detrimental to Australia’s national interest and domestic gas…
The 7 stocks at risk of a reporting day sell-off
UBS has named seven ASX-listed blue-chip stocks that are at risk of following Commonwealth Bank into a post earnings season sell-off, with the broker warning the market appears less willing to support lofty valuations without the profit…
ASX to slide; CSL ups dividend by 12pc, Judo profit soars
Australian shares are poised to open lower. US equities were little changed in afternoon trading, with investors looking ahead to a speech by Federal Reserve chairman Jerome Powell later in the week. On Tuesday’s reporting…